APOE and Alzheimer disease: First, this study highlights the limitations of using an EHR cohort for analyzing all‐cause dementia, particularly due to the difficulty in differentiating AD from other causes of dementia and the differential effect of APOE4 allelic dose across ethnoracial groups.